PMID- 35295417 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220721 IS - 2673-561X (Electronic) IS - 2673-561X (Print) IS - 2673-561X (Linking) VI - 2 DP - 2021 TI - Kinesiophobia Severity Categories and Clinically Meaningful Symptom Change in Persons With Achilles Tendinopathy in a Cross-Sectional Study: Implications for Assessment and Willingness to Exercise. PG - 739051 LID - 10.3389/fpain.2021.739051 [doi] LID - 739051 AB - Objectives: (1) Validate thresholds for minimal, low, moderate, and high fear of movement on the 11-item Tampa Scale of Kinesiophobia (TSK-11), and (2) Establish a patient-driven minimal clinically important difference (MCID) for Achilles tendinopathy (AT) symptoms of pain with heel raises and tendon stiffness. Methods: Four hundred and forty-two adults with chronic AT responded to an online survey, including psychosocial questionnaires and symptom-related questions (severity and willingness to complete heel raises and hops). Kinesiophobia subgroups (Minimal /= 36 scores on the TSK-11), pain MCID subgroups (10-, 20-, 30-, >30-points on a 0- to 100-point scale), and stiffness MCID subgroups (5, 10, 20, >20 min) were described as median [interquartile range] and compared using non-parametric statistics. Results: Subgroups with higher kinesiophobia reported were less likely to complete three heel raises (Minimal = 93%, Low = 74%, Moderate = 58%, High = 24%). Higher kinesiophobia was associated with higher expected pain (Minimal = 20.0 [9.3-40.0], Low = 43.0 [20.0-60.0], Moderate = 50.0 [24.0-64.0], High = 60.5 [41.3-71.0]) yet not with movement-evoked pain (Minimal = 25.0 [5.0-43.0], Low = 31.0 [18.0-59.0], Moderate = 35.0 [20.0-60.0], High = 43.0 [24.0-65.3]). The most common pain MCID was 10 points (39% of respondents). Half of respondents considered a 5-min (35% of sample) or 10-min (16%) decrease in morning stiffness as clinically meaningful. Conclusions: Convergent validity of TSK-11 thresholds was supported by association with pain catastrophizing, severity of expected pain with movement, and willingness to complete tendon loading exercises. Most participants indicated that reducing their pain severity to the mild range would be clinically meaningful. CI - Copyright (c) 2021 Chimenti, Post, Silbernagel, Hadlandsmyth, Sluka, Moseley and Rio. FAU - Chimenti, Ruth L AU - Chimenti RL AD - Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA, United States. FAU - Post, Andrew A AU - Post AA AD - Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA, United States. FAU - Silbernagel, Karin Gravare AU - Silbernagel KG AD - Department of Physical Therapy, University of Delaware, Newark, DE, United States. FAU - Hadlandsmyth, Katherine AU - Hadlandsmyth K AD - Department of Anesthesia, Carver College of Medicine, University of Iowa, Iowa City, IA, United States. FAU - Sluka, Kathleen A AU - Sluka KA AD - Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA, United States. FAU - Moseley, G Lorimer AU - Moseley GL AD - Sansom Institute for Health Research, IIMPACT in Health, University of South Australia, Adelaide, SA, Australia. FAU - Rio, Ebonie AU - Rio E AD - School of Allied Health, LaTrobe Sport and Exercise Medicine Research Center, La Trobe University, Bundoora, VIC, Australia. LA - eng GR - R00 AR071517/AR/NIAMS NIH HHS/United States GR - UL1 TR002537/TR/NCATS NIH HHS/United States PT - Journal Article DEP - 20210901 PL - Switzerland TA - Front Pain Res (Lausanne) JT - Frontiers in pain research (Lausanne, Switzerland) JID - 9918227269806676 PMC - PMC8915659 OTO - NOTNLM OT - catastrophizing OT - chronic pain OT - fear of movement OT - minimal clinically importance difference OT - tendinopathy COIS- KGS receives speaker honoraria for talks on tendon injuries and for serving as an editor for Journal of Sports Physical Therapy. KAS serves as a consultant for Pfizer Consumer Health, Novartis Consumer Healthcare/GSK Consumer Healthcare, and receives royalties from IASP Press. GM receives royalties for key resources used for PNE (Explain Pain, Explain Pain Handbook: Protectometer, Explain Pain Supercharged, NOIgroup Publications, Adelaide, Australia), speaker fees for talks on contemporary pain education and has received support from: Reality Health, ConnectHealth UK, Seqirus, Kaiser Permanente, Workers' Compensation Boards in Australia, Europe and North America, AIA Australia, the International Olympic Committee, Port Adelaide Football Club, Arsenal Football Club. Professional and scientific bodies have reimbursed him for travel costs related to presentation of research on pain at scientific conferences/symposia. ER receives speaker fees for talks on tendinopathy and consults with various organizations on tendinopathy. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/03/18 06:00 MHDA- 2022/03/18 06:01 PMCR- 2021/09/01 CRDT- 2022/03/17 05:09 PHST- 2021/07/09 00:00 [received] PHST- 2021/08/10 00:00 [accepted] PHST- 2022/03/17 05:09 [entrez] PHST- 2022/03/18 06:00 [pubmed] PHST- 2022/03/18 06:01 [medline] PHST- 2021/09/01 00:00 [pmc-release] AID - 10.3389/fpain.2021.739051 [doi] PST - epublish SO - Front Pain Res (Lausanne). 2021 Sep 1;2:739051. doi: 10.3389/fpain.2021.739051. eCollection 2021.